您要查找的是不是：
- The treatment of metastatic breast cancer requires the mind of a biologist and the heart of a caring physician. 转移性乳腺癌的治疗需要我们具有生物学家的头脑和医生的人道主义精神。
- Some research shows that only about 25% of newly discovered metastatic breast cancer patients live for 5 years. 有些研究表明只有大约25%25初期的已经转移的乳腺癌患者可以生存5年。
- Capecitabine is already approved for use in colorectal cancer and metastatic breast cancer. 卡培他滨已被批准用于结肠直肠癌和乳腺转移癌。
- Metronomic chemotherapy is expected to become a novel treatment model for metastatic breast cancer. 节拍化疗有望成为转移性乳腺癌一种全新的治疗模式。
- Sledge GW.Cisplatin as first-time therapy for metastatic breast cancer[J].J Clin Oncol,1988,16(6):1811. 李震.;恶性肿瘤的化学治疗与免疫治疗
- Objective: Study clinical effect of therapeutic alliance to metastatic breast cancer with paclitaxel and mitoxantone. 目的:本文用紫杉醇与米托蒽醌联合治疗转移性乳腺癌,从而评价其临床使用效果。
- Background : Bendamustine, a bifunctional alkylating agent with anticipated purin-like properties is active in metastatic breast cancer (MBC) patients. 苯达莫司汀，具有烷化剂和嘌呤类似的双相功能可以在转移性乳腺癌（MBC）患者中发挥作用。
- Option #6, Taxotere + Xeloda was compared to Taxotere monotherapy in a randomized trial of first line chemotherapy for metastatic breast cancer. 选项%236，泰索帝＋希罗达曾在转移性乳腺癌的一线化疗中与泰索帝单药做过随机对照研究。
- Results: The five tumors included one epidermoid cyst, one ependymoma, one astrocytoma, one cavernous angioma, and one metastatic breast breast cancer. 结果：5例第四脑室肿瘤包括，1例表皮样囊种、1例室管膜瘤、1例星状细胞瘤、1例海绵状血管瘤、1例乳癌的脑转移。
- Option #6, Taxotere Xeloda was compared to Taxotere monotherapy in a randomized trial of first line chemotherapy for metastatic breast cancer. 选项%236，泰索帝+希罗达曾在转移性乳腺癌的一线化疗中与泰索帝单药做过随机对照研究。
- The efficacy of local treatment of metastatic breast cancer and the potential of imaged-guided ablation of breast cancer are under investigation. 转移性乳癌的局部治疗，及影像指引下乳癌除去术的治疗效果尚在研究中。
- In clinical trials, it was found that trastuzumab could lengthen the survival of patients with both early-stage and metastatic breast cancer. 临床试验发现，贺癌平可延长乳癌初期和后期转移病患的寿命。
- Xeloda is the only FDA-approved oral chemotherapy for both metastatic breast cancer and adjuvant and metastatic colorectal cancer. 希罗达是FDA唯一批准的转移性乳腺癌和转移性结直肠癌口服化疗药物。
- Objective: Exploring a new therapy for metastasis breast cancer. 目的:探索转移性乳腺癌的治疗新方法。
- The most effective cytotoxic drugs for treatment of metastatic breast cancer are capecitabine, doxorubicin, gemcitabine, the taxanes paclitaxel and docetaxel, and vinorelbine. 治疗转移性乳腺癌的最有效细胞毒类药有卡培他滨、阿霉素、二氟脱氧胞嘧啶、紫杉烷类（紫杉醇和紫杉萜[泰素帝]）、长春瑞滨等。
- Conclusion: Remediable physical impairments were prevalent and poorly addressed among patients with metastatic breast cancer, drastically so in the outpatient setting. 结论：可治疗的体格缺陷是普遍的，广泛存在于转移性乳腺癌患者中，更大程度上见于门诊病人。
- Seidman AD,Hudis CA,Albanel J,et al.Does-dense therapy with weekly 1-hour paclitaxel infusions in the treatment of metastatic breast cancer[J].J Clin Oncol,1998,16(10):3353. 刘芳;江泽飞;宋三泰;等.;单药紫杉醇治疗晚期乳腺癌剂量强度与疗效和毒性的关系[J]
- Importantly this study has confirmed that Avastin can be used with taxane- based chemotherapy to provide a meaningful benefit for patients with metastatic breast cancer. 重要的是这项研究证实了贝罗伐可联合紫杉类为基础的化疗，为转移性乳腺癌患者提供积极的益处。”
- Xeloda monotherapy is also indicated for treatment of patients with metastatic breast cancer that is resistant to other chemotherapy drugs such as paclitaxel and anthracyclines. 希罗达单一疗法还可治疗转移性乳腺癌患者。转移性乳腺癌对紫杉醇和蒽环类抗生素等其他化疗法具有抵抗作用。
- BISHOP M R，FOWLER D H，MARCHIGIANI D，et al.Allo-genic lymphocytes induce tumor regression of advanced metastatic breast cancer[J].J Clin Oncol，2004，22（19）:3886.3892. 徐开林，居建平，潘秀英.;非清除性异基因骨髓移植治疗小鼠白血病的实验研究[J]
